These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 33357918)

  • 21. Dual drug-loaded nano-platform for targeted cancer therapy: toward clinical therapeutic efficacy of multifunctionality.
    Ma Z; Li N; Zhang B; Hui Y; Zhang Y; Lu P; Pi J; Liu Z
    J Nanobiotechnology; 2020 Sep; 18(1):123. PubMed ID: 32887626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laser-responsive multi-functional nanoparticles for efficient combinational chemo-photodynamic therapy against breast cancer.
    Guan Q; Li Y; Zhang H; Liu S; Ding Z; Fan Z; Wang Q; Wang Z; Han J; Liu M; Zhao Y
    Colloids Surf B Biointerfaces; 2022 Aug; 216():112574. PubMed ID: 35623257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase-Change Material Packaged within Hollow Copper Sulfide Nanoparticles Carrying Doxorubicin and Chlorin e6 for Fluorescence-Guided Trimodal Therapy of Cancer.
    Li Q; Sun L; Hou M; Chen Q; Yang R; Zhang L; Xu Z; Kang Y; Xue P
    ACS Appl Mater Interfaces; 2019 Jan; 11(1):417-429. PubMed ID: 30537815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
    Gu J; Fang X; Hao J; Sha X
    Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paclitaxel and quercetin co-loaded functional mesoporous silica nanoparticles overcoming multidrug resistance in breast cancer.
    Liu M; Fu M; Yang X; Jia G; Shi X; Ji J; Liu X; Zhai G
    Colloids Surf B Biointerfaces; 2020 Dec; 196():111284. PubMed ID: 32771817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A targeted and redox/pH-responsive chitosan oligosaccharide derivatives based nanohybrids for overcoming multidrug resistance of breast cancer cells.
    Jia L; Li Z; Zheng D; Li Z; Zhao Z
    Carbohydr Polym; 2021 Jan; 251():117008. PubMed ID: 33142574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Near-infrared triggered co-delivery of doxorubicin and quercetin by using gold nanocages with tetradecanol to maximize anti-tumor effects on MCF-7/ADR cells.
    Zhang Z; Xu S; Wang Y; Yu Y; Li F; Zhu H; Shen Y; Huang S; Guo S
    J Colloid Interface Sci; 2018 Jan; 509():47-57. PubMed ID: 28881205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Doxorubicin-loaded pH-responsive nanoparticles coated with chlorin e6 for drug delivery and synergetic chemo-photodynamic therapy.
    Liang J; Jin X; Chen B; Hu J; Huang Q; Wan J; Hu Z; Wang B
    Nanotechnology; 2020 May; 31(19):195103. PubMed ID: 31978912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PEGylated hydrazided gold nanorods for pH-triggered chemo/photodynamic/photothermal triple therapy of breast cancer.
    Xu W; Qian J; Hou G; Wang Y; Wang J; Sun T; Ji L; Suo A; Yao Y
    Acta Biomater; 2018 Dec; 82():171-183. PubMed ID: 30336271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Co-delivery of Paclitaxel/Atovaquone/Quercetin to regulate energy metabolism to reverse multidrug resistance in ovarian cancer by PLGA-PEG nanoparticles.
    Lu Q; Gao W; Chen Z; Liu Z; Wang J; Zeng L; Hu X; Zheng E; Zhang Q; Song H
    Int J Pharm; 2024 Apr; 655():124028. PubMed ID: 38518871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Y
    Wang Y; Jiang Z; Yuan B; Tian Y; Xiang L; Li Y; Yang Y; Li J; Wu A
    Biomater Sci; 2019 Nov; 7(11):4748-4757. PubMed ID: 31508613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles.
    Wu Y; Zhang Y; Zhang W; Sun C; Wu J; Tang J
    Colloids Surf B Biointerfaces; 2016 Feb; 138():60-9. PubMed ID: 26655793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overcoming the diverse mechanisms of multidrug resistance in lung cancer cells by photodynamic therapy using pTHPP-loaded PLGA-lipid hybrid nanoparticles.
    Pramual S; Lirdprapamongkol K; Jouan-Hureaux V; Barberi-Heyob M; Frochot C; Svasti J; Niamsiri N
    Eur J Pharm Biopharm; 2020 Apr; 149():218-228. PubMed ID: 32112893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NIR-Triggered Sequentially Responsive Nanocarriers Amplified Cascade Synergistic Effect of Chemo-Photodynamic Therapy with Inspired Antitumor Immunity.
    Jin F; Qi J; Zhu M; Liu D; You Y; Shu G; Du Y; Wang J; Yu H; Sun M; Xu X; Shen Q; Ying X; Ji J; Du Y
    ACS Appl Mater Interfaces; 2020 Jul; 12(29):32372-32387. PubMed ID: 32597641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reactive oxygen species and near-infrared light dual-responsive indocyanine green-loaded nanohybrids for overcoming tumour multidrug resistance.
    Wang M; Xiao Y; Li Y; Wu J; Li F; Ling D; Gao J
    Eur J Pharm Sci; 2019 Jun; 134():185-193. PubMed ID: 31026507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-metastatic and pro-apoptotic effects elicited by combination photodynamic therapy with sonodynamic therapy on breast cancer both in vitro and in vivo.
    Wang P; Li C; Wang X; Xiong W; Feng X; Liu Q; Leung AW; Xu C
    Ultrason Sonochem; 2015 Mar; 23():116-27. PubMed ID: 25465095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversal of doxorubicin-resistance by multifunctional nanoparticles in MCF-7/ADR cells.
    Shieh MJ; Hsu CY; Huang LY; Chen HY; Huang FH; Lai PS
    J Control Release; 2011 Jun; 152(3):418-25. PubMed ID: 21435362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic chemo-photodynamic therapy mediated by light-activated ROS-degradable nanocarriers.
    Chen Y; Gao Y; Li Y; Wang K; Zhu J
    J Mater Chem B; 2019 Jan; 7(3):460-468. PubMed ID: 32254733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of ultrasound exposure on P-glycoprotein-mediated multidrug resistance in vitro and in vivo.
    Huang C; Huang S; Li H; Li X; Li B; Zhong L; Wang J; Zou M; He X; Zheng H; Si X; Liao W; Liao Y; Yang L; Bin J
    J Exp Clin Cancer Res; 2018 Sep; 37(1):232. PubMed ID: 30231924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new NIR-triggered doxorubicin and photosensitizer indocyanine green co-delivery system for enhanced multidrug resistant cancer treatment through simultaneous chemo/photothermal/photodynamic therapy.
    Yu Y; Zhang Z; Wang Y; Zhu H; Li F; Shen Y; Guo S
    Acta Biomater; 2017 Sep; 59():170-180. PubMed ID: 28629893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.